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Introduction
Preoperative evaluation of clinically localized prostate cancer
to select the best candidates for radical prostatectomy remains
a challenge. This is because the presence of extracapsular
disease is an important predictor of outcome after radical
prostatectomy and may significantly influence biological and
clinical recurrence.1 Currently, a combination of serum pros-
tate-specific antigen (PSA), clinical staging with digital rectal
examination (DRE) and Gleason score is used to predict patho-
logical stage of localized prostate cancer using Partin’s table.2
Staging by DRE and transrectal ultrasound (TRUS) is often of
limited accuracy.3 DRE has accuracies ranging from 44% to
82%, and TRUS from 58% to 86%.4,5 Magnetic resonance
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imaging (MRI) of the prostate can potentially reveal local
tumour extension. Current literature shows that MRI of the
prostate is most suitable for patients with intermediate risk.6
It can be performed with a phased-array coil, which is placed
externally over the pelvis, or an endorectal coil. The phased-
array coil is more commonly available than the endorectal coil.
Husband et al have shown that phased-array coil MRI of the
prostate yields superior image quality.7 Other investigators,
however, have shown that endorectal MRI is superior to phased-
array MRI due to a better signal-to-noise ratio.8,9 We describe
our experience with phased-array MRI of the prostate, and
evaluate its sensitivity, specificity and accuracy by correlating
MRI results with whole-mount step-sectioned radical prosta-
tectomy specimens.
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METHODS: The study population was 21 patients who underwent preoperative MRI with pelvic phased-array
coils followed by radical prostatectomy. The MRI findings were correlated with completely embedded serially
sliced and whole-mounted sections of the prostate gland and clinical staging.
RESULTS: Overall accuracy of 57.1% was obtained, with specificity of 90.0% and sensitivity of 27.3%. All but one
case of locally advanced disease missed by MRI was microscopic. Clinical staging in these cases also achieved
accuracy of 57.1%, specificity of 90.0% and sensitivity of 27.3%.
CONCLUSIONS: MRI with a phased-array coil has high specificity but low sensitivity for detection of
extraprostatic disease. Phased-array MRI does not image microscopic tumour extension. It did not perform better
than clinical staging and is not recommended for routine staging. [Asian J Surg 2004;27(3):219–24]
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Patients and methods
Patients and clinical staging
Between April 1999 and December 2001, we performed 40
radical prostatectomies in our centre. All patients had biopsy-
proven prostate cancer before radical prostatectomy. Our study
population consisted of 21 patients who underwent pre-
operative MRI before radical prostatectomy. None of the pa-
tients were deprived of surgery based on preoperative MRI
findings. Except for one patient who delayed his operation
for 89 days for social reasons, patients underwent radical
prostatectomy within about 4 weeks of MRI. Patient mean
age was 62.5 years (range, 50–74 years). Median serum PSA
was 15.0 µg/L (range, 5.5–65.9 µg/L). The median Gleason
score was 6.5 (range, 5–8) based on TRUS biopsy specimens
(Table). Patients were assigned a clinical stage based on DRE
findings.
Imaging studies
MRI examinations were performed using two 1.5T MRI
systems (GE Signa LX, GE Medical Systems, Milwaukee, WI,
USA; Siemens Magnetom Vision, Siemens Corporation,
Erlangen, Germany). With pelvic phased-array coils in place,
axial T1-weighted spin-echo (SE) images were obtained from
the symphysis pubis to the aortic bifurcation with the follow-
ing parameters: TR (repetition time) 600 msec, TE (echo time)
12 msec, 4 mm section thickness, 1 mm intersection gap, two
signals averaged, 24 cm field of view (FOV), and matrix size
of 320 × 356. This was followed by acquisition of transaxial
and coronal T2-weighted fast SE images with the following
parameters: TR 4,000 msec, TE 118–132 msec, 4 mm section
with 1 mm intersection gap, 15–22 echo train, 2–4 signals
averaged (NEX), 14–22 cm FOV, and a matrix size of 320 ×
256, with right-to-left phase coding. An endorectal coil was
not used.
Image analysis
Prior to surgery, all MR images were interpreted and reported
by a single reader. The findings on these radiological reports
were analysed to calculate the accuracy, sensitivity and
specificity. Radiological-pathological correlation was per-
formed in the presence of the radiologist and the pathologist
after the radical prostatectomy specimens had been patho-
logically evaluated.
Table. Age, time between magnetic resonance imaging (MRI) and radical prostatectomy, serum prostate-specific antigen (PSA),





Preop MRI findings Clinical stage Pathological stageoperation (d) score
66 14 16.3 5 Conf T1c T2aN0Mx
50 11 18.0 6 Conf T1c T2cN0Mx
63 12 a6.5 6 Conf T1c T3aN0Mx
74 10 10.7 7 Conf T2a T3bN0Mx
69 10 15.2 7 Conf T3a T2cN0Mx
61 89 19.0 6 Conf T2a T3aN0Mx
68 a9 a9.5 7 Conf T2a T3aN0Mx
62 a3 13.5 7 Conf T1b T2cN0Mx
62 29 15.0 7 Bilateral SV T1b T2bN0Mx
62 a1 24.8 8 Bilateral SV T3a T3bN2Mx
67 10 a7.1 5 Conf T1c T2bN0Mx
60 10 13.0 7 Conf T1c T3aN0Mx
64 29 a6.5 5 Conf T1c T2cN0Mx
72 a1 18.2 8 Conf T1c T3aN0Mx
62 a7 65.9 7 Conf T1c T3aN0Mx
61 10 74.3 6 Conf T2a T2aN0Mx
61 a8 18.1 7 Left NVB T3a T3aN0Mx
59 10 46.9 7 Conf T3a T3bN0Mx
65 a7 10.1 6 Conf T1c T2bN0Mx
54 14 a5.5 7 Conf T1c T2aN0Mx
51 19 12.8 6 Right SV T2a T3bN0Mx
Conf = radiologically confined to gland, no evidence of local extension; SV = radiological seminal vesicle extension; NVB = radiological
neurovascular bundle involvement.
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We adapted our criteria for MR image analysis from Hricak
et al’s study.8 Criteria for extracapsular and neurovascular
bundle extension included localized bulge with irregular
margin; angular bulge at the posterolateral margin of the
gland; asymmetry of the neurovascular bundle; and breach of
the capsule with direct tumour extension. Criteria for invasion
of the seminal vesicle included demonstration of low-signal-
intensity tumour extension from the base of the gland into
and around the seminal vesicles that resulted in low signal
intensity of the involved seminal vesicles and obliteration of
the angle between the prostate and the seminal vesicle; tumour
extension along the ejaculatory ducts that resulted in the non-
visualization of the ducts, decreased signal intensity of the
seminal vesicles and loss of the seminal vesicle wall on the T2-
weighted images; and isolated foci (skip metastases) of low
signal intensity in the seminal vesicles on T2-weighted images.
Histological evaluation
The prostate gland was fixed in 10% buffered formaldehyde
after surgical resection. It was then axially sectioned at ap-
proximately 5 mm intervals in a plane perpendicular to the
long axis (base to apex) of the gland. The anterior, posterior,
right lateral and left lateral margins were coated with differ-
ent coloured ink, and the gland was completely embedded for
histological examination. Microscopic examination deter-
mined the Gleason’s grades and score, tumour extent, ex-
tracapsular penetration, and seminal vesicle and surgical mar-
gin involvement. Extracapsular extension was defined as full-
thickness capsular penetration with cancer extension into the
periprostatic soft tissue.1 Invasion into but not through the
capsule was categorized as organ-confined disease.1 Seminal
vesicle invasion was defined as invasion into or through the
muscular wall of the seminal vesicle.10
Sensitivity, specificity and accuracy
To calculate the sensitivity, specificity and accuracy of MRI,
true positive was defined as imaging diagnosis of local exten-
sion confirmed by radiological-pathological correlation. To
calculate the sensitivity, specificity and accuracy of clinical
staging, true positive was defined as DRE findings of local
extension confirmed by pathology.
Results
Surgical pathological findings
Pathological staging according to the TNM system demon-
strated T2a in three patients, T2b in three, T2c in four, T3a in
seven and T3b in four.11 Two dissected obturator lymph nodes
were positive for malignancy in one patient, but these lymph
nodes were less than 1 cm in size.
MRI findings
We correctly staged nine cases of organ-confined disease, one
case with neurovascular involvement (Figure 1) and two cases
with seminal vesicle involvement (Figure 2). One case of organ-
confined disease was falsely reported as having bilateral semi-
nal vesicle involvement.
Six cases of microscopic capsular invasion and one case of
microscopic seminal vesicle involvement were missed. Both
the pathologist and radiologist agreed that the degree of
invasion was beyond imaging resolution in these cases. An-
other case with right seminal vesicle and neurovascular bundle
involvement was reported as organ-confined disease. Review
of the MR images of this case showed an isolated focus of low
signal intensity in the right seminal vesicle that was identified
retrospectively during the radiological-pathological correla-
tion (Figure 3).
In the case with metastases to two obturator lymph nodes,
the involved lymph nodes were less than 1 cm in short axis
diameter on MRI and were reported as not enlarged. Actual
surgical specimens of the involved lymph nodes were also less
than 1 cm in size.
Overall, we achieved a low sensitivity of 27.3% (95% confi-
dence interval, 95% CI, 9.7%, 56.6%), a high specificity of 90.0%
(95% CI, 59.6%, 98.2%) and a moderate accuracy of 57.1%. The
positive and negative predictive values were 75.0% and 52.9%,
respectively.
Clinical staging findings
Nine cases of organ-confined disease and three cases of local-
ly advanced disease were correctly staged. One case of organ-
confined disease was overstaged and eight cases of locally
advanced disease were understaged. Overall, the results were
identical to MR staging, with sensitivity of 27.3%, specificity of
90.0% and accuracy of 57.1%. The positive and negative predic-
tive values were 75.0% and 52.9%.
Discussion
MRI with and without endorectal coils has been investigated
with a view to improving the accuracy of local staging of
prostate cancer, but, thus far, is not recommended for routine
local staging of prostate cancer.12 Endorectal MRI is generally
considered superior to phased-array MRI in the assessment of
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Figure 1. Stage pT3a carcinoma of the prostate gland. A) Pelvic phased-array axial T2-weighted image demonstrates a thickened left
neurovascular bundle (arrow). B) Corresponding step section of the whole-mount prostatectomy specimen shows invasion by malignant
acini around the left neurovascular bundle (arrow). C) Light microscopy confirms the presence of perineural invasion, and D) invasion into





Figure 2. Stage pT3c carcinoma of the prostate gland. A) Pelvic phased-array axial T2-weighted image shows direct contiguous extension
of tumour with low signal into and around both seminal vesicles (arrows), indicating bilateral seminal vesicle involvement. B) Cor-
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Figure 3. Stage pT3c carcinoma of the prostate gland. A) Pelvic
phased-array axial T2-weighted image shows the low-signal tumour
(T) in the right lobe of the prostate gland. The skipped focus of low
signal in the right seminal vesicle was missed initially (arrow). B) The
corresponding whole-mount step-section specimen shows invasion
by malignant acini (arrow) into the right seminal vesicle. C) Light
microscopy shows the malignant acini (arrow) invading the muscu-







sensitivity and specificity of the endorectal coil for detection of
locally advanced disease is 13% to 89% and 67% to 97%.8,9,13–15
Although Ikonen et al achieved a very high specificity of
97% with an endorectal coil at the expense of a low sensitivity
of 13% for the diagnosis of locally advanced prostate carcino-
ma,16 most other studies using an endorectal coil show higher
sensitivity than with a pelvic phased-array coil alone.
The reported performance of phased-array MRI of the
prostate to detect locally advanced carcinoma of the prostate
is modest, with sensitivities of 33% to 74%, and specificities of
67% to 93%.8,9,17 However, the phased-array coil is more readily
available in clinical practice and does not have the discomfort
of endorectal coil insertion. Husband et al have shown that
image quality from phased-array coils can be superior to
endorectal coils.7
Our study shows similar high specificity (90.0%), low sen-
sitivity (27.3%) and moderate accuracy (57.1%) to Hricak et al’s
study with a phased-array coil.8 Overall, phased-array MRI
performed poorly, with similar results to clinical staging.
In our study, strict objective criteria adopted for the diag-
nosis of locally advanced disease ensured that a high specifi-
city was achieved with the pelvic phased-array coil. This en-
sured that patients were not overstaged and deprived of poten-
tially curative surgery. However, our sensitivity was low. In our
pathological correlation, in all but one case of missed tumour
extension, extension was microscopic. Therefore, phased-
array MRI can detect macroscopic extension, but clinicians
and radiologists should be aware of the low sensitivity
achieved with this modality and the difficulties in detect-
ing microscopic local extension.
D’Amico et al have shown that MRI may play a comple-
mentary role in the clinical staging of adenocarcinoma of the
prostate6 and is most useful in patients with intermediate
risks based on Partin’s nomogram (Gleason score of 6–7 and
serum PSA of 10–20 ng/mL). Endorectal MRI in this group of
patients is an independent predictor of 5-year PSA failure.6
MRI in these patients can aid in patient selection for surgery
and improved surgical outcome.
Endorectal coils, which our centre has recently acquired
after completion of this study, may improve our sensitivity
while maintaining the high specificity. Further reader experi-
ence may also improve our result.8
Conclusion
Phased-array MRI of the prostate performed poorly, giving
similar results to clinical staging. It has a low sensitivity and
local extension.8,9 This is due to a higher signal-to-noise ratio
with the coil in the rectum closer to the prostate. The reported
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high specificity for the detection of local tumour extension in
carcinoma of the prostate. Although phased-array coils are
more readily available in imaging facilities, they are not rec-
ommended for routine staging as microscopic extension is
difficult to detect.
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